Merck Research and Development Expenses 2010-2024 | MKKGY

Merck annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Merck research and development expenses for the quarter ending June 30, 2024 were $0.697B, a 6.5% increase year-over-year.
  • Merck research and development expenses for the twelve months ending June 30, 2024 were $2.679B, a 0.89% increase year-over-year.
  • Merck annual research and development expenses for 2023 were $2.646B, a 0.37% decline from 2022.
  • Merck annual research and development expenses for 2022 were $2.656B, a 6.77% decline from 2021.
  • Merck annual research and development expenses for 2021 were $2.849B, a 9% increase from 2020.
Merck Annual Research and Development Expenses
(Millions of US $)
2023 $2,646
2022 $2,656
2021 $2,849
2020 $2,614
2019 $2,540
2018 $2,628
2017 $2,419
2016 $2,187
2015 $1,897
2014 $2,265
2013 $1,998
2012 $1,944
2011 $2,113
2010 $
2009 $
Merck Quarterly Research and Development Expenses
(Millions of US $)
2024-06-30 $697
2024-03-31 $631
2023-12-31 $719
2023-09-30 $632
2023-06-30 $654
2023-03-31 $641
2022-12-31 $713
2022-09-30 $647
2022-06-30 $639
2022-03-31 $658
2021-12-31 $674
2021-09-30 $778
2021-06-30 $705
2021-03-31 $692
2020-12-31 $782
2020-09-30 $621
2020-06-30 $573
2020-03-31 $639
2019-12-31 $699
2019-09-30 $620
2019-06-30 $622
2019-03-31 $599
2018-12-31 $724
2018-09-30 $630
2018-06-30 $642
2018-03-31 $632
2017-12-31 $678
2017-09-30 $641
2017-06-30 $573
2017-03-31 $528
2016-12-31 $591
2016-09-30 $494
2016-06-30 $561
2016-03-31 $539
2015-12-31 $430
2015-09-30 $464
2015-06-30 $504
2015-03-31 $498
2014-12-31 $536
2014-09-30 $668
2014-06-30 $541
2014-03-31 $519
2013-12-31 $471
2013-09-30 $502
2013-06-30 $488
2013-03-31 $537
2012-12-31
2012-09-30 $464
2012-06-30 $519
2012-03-31
2011-12-31
2011-09-30
2011-06-30 $531
2011-03-31
2010-12-31
2010-09-30 $450
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00